CN110981834A - 一种一氧化氮前体化合物的制备方法及其安全性评价 - Google Patents
一种一氧化氮前体化合物的制备方法及其安全性评价 Download PDFInfo
- Publication number
- CN110981834A CN110981834A CN201911333018.2A CN201911333018A CN110981834A CN 110981834 A CN110981834 A CN 110981834A CN 201911333018 A CN201911333018 A CN 201911333018A CN 110981834 A CN110981834 A CN 110981834A
- Authority
- CN
- China
- Prior art keywords
- nitric oxide
- oxide precursor
- compound
- precursor compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911333018.2A CN110981834A (zh) | 2019-12-20 | 2019-12-20 | 一种一氧化氮前体化合物的制备方法及其安全性评价 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911333018.2A CN110981834A (zh) | 2019-12-20 | 2019-12-20 | 一种一氧化氮前体化合物的制备方法及其安全性评价 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110981834A true CN110981834A (zh) | 2020-04-10 |
Family
ID=70073884
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911333018.2A Pending CN110981834A (zh) | 2019-12-20 | 2019-12-20 | 一种一氧化氮前体化合物的制备方法及其安全性评价 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110981834A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190106396A1 (en) * | 2017-10-10 | 2019-04-11 | Arizona Board Of Regents On Behalf Of Arizona State University | Bis-diazeniumdiolate compounds as anti-cancer agents |
-
2019
- 2019-12-20 CN CN201911333018.2A patent/CN110981834A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190106396A1 (en) * | 2017-10-10 | 2019-04-11 | Arizona Board Of Regents On Behalf Of Arizona State University | Bis-diazeniumdiolate compounds as anti-cancer agents |
Non-Patent Citations (2)
Title |
---|
VARUN KUMAR ET AL.: ""Stabilization of the Nitric Oxide (NO) Prodrugs and Anticancer Leads, PABA/NO and Double JS-K, through Incorporation into PEG-Protected Nanoparticles"", 《MOLECULAR PHARMACEUTICS》 * |
XUN JIA ET AL.: ""Double-component diazeniumdiolate derivatives as anti-cancer agents"", 《BIOORGANIC & MEDICINAL CHEMISTRY》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101362702B (zh) | 大黄素衍生物及其在制备抗癌药物中的应用 | |
MX2007000457A (es) | Inhibidores de indoleamina 2,3-dioxigenasa (ido). | |
CN109912607B (zh) | 一类卟啉-白杨素复合物及其抗肿瘤活性 | |
JP2019533635A (ja) | 新規なジヒドロポルフィンe6誘導体及びその薬学的に許容される塩、その調製方法並びに使用 | |
JP4540986B2 (ja) | ワートマニン類似体およびそれらを用いる方法 | |
CN113831351A (zh) | 一类新型四吡咯衍生物及其应用 | |
CN114478450A (zh) | 苄氧基苯酞类化合物、其制备方法和用途 | |
CA1169081A (en) | 8-aminoalkyl-4-alkylisopsoralens | |
JP5950390B2 (ja) | 新規ミモシン誘導体 | |
CN110981834A (zh) | 一种一氧化氮前体化合物的制备方法及其安全性评价 | |
CN114920710A (zh) | 亚氨脲衍生物 | |
EP0552880B1 (en) | Anticancer benzaldehyde compounds | |
CN112175014B (zh) | 一种一氧化氮供体型四价铂衍生物、制备方法及其医药用途 | |
KR100841901B1 (ko) | 플라보노이드 계열 화합물 또는 이를 포함하는 강진향추출물을 함유한 매트릭스 메탈로프로테이나제 활성저해제 및 기능성 식품 | |
NZ748656A (en) | Amide derivatives of polycaffeoylquinic acids, process for producing same and uses thereof | |
CN115160399B (zh) | 一种皂皮酸类化合物及其制备方法和医用用途 | |
JP4328848B2 (ja) | 細胞代謝の調整体としての線形構造の[ポリ―(2,5―ジヒドロキシフェニレン)]―4―チオ硫酸のナトリウム塩及びその製造方法 | |
CN110698538A (zh) | 一种基于酪氨酸偶联的环肽化合物及其制备与应用 | |
JP5916348B2 (ja) | 新規セロトニン化合物及びチロシナーゼ阻害剤、及び変色防止剤 | |
CN113304129B (zh) | 单烯酮类单羰基姜黄素类似物在制备抗氧化药物的应用 | |
RU2814111C1 (ru) | Производные 5,8-диметокси-6,7-метилендиокси кумарина, обладающие антирадикальной активностью | |
JP2010037247A (ja) | グルタチオン産生促進剤 | |
CN115197113B (zh) | 含硫脲结构的Combretastatin A-4衍生物、其制备方法及其用途 | |
JP2012102040A (ja) | 抗老化剤及び老化防止用皮膚外用剤 | |
Alidmat et al. | Synthesis, Characterization, Cytotoxicity Study and Docking Studies of New Fused-pyrazoline Derivatives derived from Bis-Chalcones Against Breast Cancer cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
DD01 | Delivery of document by public notice |
Addressee: HANGZHOU JINCHI MEDICAL INSTRUMENT Co.,Ltd. Person in charge of patentsThe principal of patent Document name: First notice of examination opinions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: HANGZHOU JINCHI MEDICAL INSTRUMENT Co.,Ltd. Person in charge of patentsThe principal of patent Document name: Notice of examination opinions |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: HANGZHOU JINCHI MEDICAL INSTRUMENT Co.,Ltd. Person in charge of patentsThe principal of patent Document name: Deemed withdrawal notice |
|
DD01 | Delivery of document by public notice | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200410 |
|
WD01 | Invention patent application deemed withdrawn after publication |